Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Linkage Global A | LGCB | Mar 14, 2025 | 0.18 | -22.20 |
Linkbancorp | LNKB | Mar 14, 2025 | 6.90 | +3.14 |
Linkers Industries | LNKS | Mar 14, 2025 | 0.55 | -2.10 |
Lion ADR | LGHL | Mar 14, 2025 | 0.10 | +2.69 |
Lionheart Units | CUBWU | Mar 14, 2025 | 10.22 | 0.00 |
Lions Gate Entertainment A | LGF-A | Mar 14, 2025 | 9.22 | +0.77 |
Lions Gate Entertainment B | LGF-B | Mar 14, 2025 | 8.21 | +0.61 |
Lipella Pharmaceuticals | LIPO | Mar 14, 2025 | 2.15 | -1.83 |
Lipocine | LPCN | Mar 14, 2025 | 3.35 | +1.52 |
LiqTech International | LIQT | Mar 14, 2025 | 1.44 | +3.60 |
Liquidia | LQDA | Mar 14, 2025 | 14.43 | +2.85 |
Liquidity Services | LQDT | Mar 14, 2025 | 29.83 | +1.95 |
Lisata Therapeutics | LSTA | Mar 14, 2025 | 2.39 | +3.02 |
Lithia Motors | LAD | Mar 14, 2025 | 295.51 | +3.47 |
Lithium Americas | LAC | Mar 14, 2025 | 2.90 | +3.94 |
Lithium Argentina AG | LAR | Mar 14, 2025 | 2.23 | 0.00 |
Littelfuse | LFUS | Mar 14, 2025 | 210.51 | +2.64 |
LivaNova | LIVN | Mar 14, 2025 | 39.24 | +1.76 |
Live Nation Entertainment | LYV | Mar 14, 2025 | 119.26 | +3.00 |
Live Oak Acquisition Corp. V - Units | LOKVU | Mar 14, 2025 | 10.05 | 0.00 |
Live Oak Bancshares | LOB | Mar 14, 2025 | 28.62 | +3.40 |
Live Ventures | LIVE | Mar 14, 2025 | 6.94 | -0.86 |
LiveOne | LVO | Mar 14, 2025 | 0.75 | +10.67 |
LivePerson | LPSN | Mar 14, 2025 | 0.98 | +6.91 |
LiveRamp | RAMP | Mar 14, 2025 | 26.33 | +2.97 |
LiveWire Group | LVWR | Mar 14, 2025 | 2.23 | +5.69 |
Lixiang Education ADR | LXEH | Mar 14, 2025 | 9.31 | +0.11 |
Lixte Biotechnology | LIXT | Mar 14, 2025 | 1.21 | +0.83 |
LKQ | LKQ | Mar 14, 2025 | 41.66 | +0.92 |
Lloyds Banking ADR | LYG | Mar 14, 2025 | 3.67 | +2.51 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.